Mirtazapine and Carbamazepine Fail to Demonstrate Clinical and Cost Effectiveness as Alzheimer Agitation Treatments - Neurology Live

Submitted by Anonymous (not verified) on Sat, 12/03/2022 - 14:05

Mirtazapine and Carbamazepine Fail to Demonstrate Clinical and Cost Effectiveness as Alzheimer Agitation Treatments  Neurology Live